Skip to main content
Veterinary Medicines

BRONCHOCANIS BIOCANINA 10 MG/ML + 0,21 MG/ML + 254,24 MG/ML SOLUTION BUVABLE EN GOUTTES POUR CHIENS ET CHATS

Authorised
  • Codeine monohydrate
  • Sodium benzoate
  • Chlorphenamine maleate

Product identification

Medicine name:
BRONCHOCANIS BIOCANINA 10 MG/ML + 0,21 MG/ML + 254,24 MG/ML SOLUTION BUVABLE EN GOUTTES POUR CHIENS ET CHATS
Active substance:
  • Codeine monohydrate
  • Sodium benzoate
  • Chlorphenamine maleate
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Codeine monohydrate
    10.60
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium benzoate
    300.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Chlorphenamine maleate
    0.30
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral drops, solution
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QR05DA04
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Domes Pharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Europeenne De Pharmacotechnie Europhartech
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/3367391 0/1985
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 26/03/2024

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/11/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."